Assessing the Performance of Deep Learning for Automated Gleason Grading in Prostate Cancer
<|reference_start|>Assessing the Performance of Deep Learning for Automated Gleason Grading in Prostate Cancer: Prostate cancer is a dominant health concern calling for advanced diagnostic tools. Utilizing digital pathology and artificial intelligence, this study explores the potential of 11 deep neural network architectures for automated Gleason grading in prostate carcinoma focusing on comparing traditional and recent architectures. A standardized image classification pipeline, based on the AUCMEDI framework, facilitated robust evaluation using an in-house dataset consisting of 34,264 annotated tissue tiles. The results indicated varying sensitivity across architectures, with ConvNeXt demonstrating the strongest performance. Notably, newer architectures achieved superior performance, even though with challenges in differentiating closely related Gleason grades. The ConvNeXt model was capable of learning a balance between complexity and generalizability. Overall, this study lays the groundwork for enhanced Gleason grading systems, potentially improving diagnostic efficiency for prostate cancer.<|reference_end|>
@article{müller2024assessing,
    title={Assessing the Performance of Deep Learning for Automated Gleason Grading
  in Prostate Cancer},
    author={Dominik M"uller, Philip Meyer, Lukas Rentschler, Robin Manz, Daniel
  Hieber, Jonas B"acker, Samantha Cramer, Christoph Wengenmayr, Bruno M"arkl,
  Ralf Huss, Frank Kramer, I~naki Soto-Rey, Johannes Raffler},
    journal={arXiv preprint arXiv:2403.16695},
    year={2024},
    archivePrefix={arXiv},
    eprint={2403.16695},
    primaryClass={eess.IV cs.CV cs.LG q-bio.TO}
}